Objective To compare acute treatment responses and long-term outcome in leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 patients with LGI1 ...

Objective Antibodies against contactin-associated protein-like 2 (CASPR2-Abs) have been described in acquired neuromyotonia, limbic encephalitis (LE) and Morvan syndrome (MoS). However, it is unknown ...

Correspondence to Jia Liu, Chinese Academy of Sciences, Shenzhen Institutes of Advanced Technology; jia.liu{at}siat.ac.cn and Dr Ka Sing Wong, Department of Medicine and Therapeutics, The Chinese ...

Background Psychogenic non-epileptic seizures (PNES) are classified with other functional neurological symptoms as ‘Conversion Disorder’, but there are reasons to wonder whether this symptomatology ...

1 Academic Neurology Unit, University of Sheffield, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK 2 Department of Liaison Psychiatry, Brandon Mental Health Unit, Leicester General ...

1 Institute of Brain and Behavior, Department of Psychiatry, University of Maastricht, Maastricht, The Netherlands 2 Department of Radiology, Academisch Ziekenhuis Maastricht, Maastricht, The ...

Anxiety is an adaptive response that promotes harm avoidance, but at the same time excessive anxiety constitutes the most common psychiatric complaint. Moreover, current treatments for anxiety—both ...

Correspondence to Dr David L Perez, Massachusetts General Hospital, Departments of Neurology and Psychiatry 149 13th Street, Charlestown, MA 02129, USA; dlperez{at}partners.org Objective Affective ...

Department of Immunobiology, King’s College London, Guy’s Hospital, London, UK Dr Jane Pritchard, c/o Department of Clinical Neuroscience, King’s College London, Guy’s Hospital, London SE1 1UL, UK; ...

1 Farr Institute of Health Informatics, University College London, London, UK 2 Stroke and Vascular Research Centre, Institute of Cardiovascular Sciences, University of Manchester, Manchester Academic ...

Background To evaluate the efficacy of rituximab in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients not responding to conventional immune therapies. Methods An open-label, ...

Dr M Prosiegel, Neuropsychological Department, Neurologisches Krankenhaus München, Munich, Germany. OBJECTIVE To determine: (1) patterns of cognitive and psychiatric dysfunction; (2) those ...